Lataa...
Management of Pediatric Systemic Lupus Erythematosus: Focus on Belimumab
Belimumab (Benlysta(®)) is a fully humanized monoclonal antibody that inhibits B lymphocyte stimulator (BLyS, also known as B cell-activating factor of the tumor necrosis factor family) and was approved by the US Food and Drug Administration (FDA) and the European Medicines Evaluation Agency for the...
Tallennettuna:
| Julkaisussa: | Drug Des Devel Ther |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7323799/ https://ncbi.nlm.nih.gov/pubmed/32612353 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S216193 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|